Table 7 Enrichment of PPI KEGG pathways by MT (FrE).
Pathway | p-Value | FDR |
|---|---|---|
MAPK signalling pathway | 1.29E-28 | 2.06E-26 |
FoxO signalling pathway | 8.09E-19 | 2.86E-17 |
HIF-1 signalling pathway | 9.65E-19 | 3.07E-17 |
PI3K-Akt signalling pathway | 1.09E-18 | 3.15E-17 |
Pancreatic cancer | 2.98E-18 | 7.29E-17 |
ErbB signalling pathway | 3.69E-18 | 8.37E-17 |
Endocrine resistance | 8.42E-18 | 1.67E-16 |
Insulin signalling pathway | 2.87E-16 | 3.65E-15 |
Insulin resistance | 1.18E-15 | 1.21E-14 |
TNF signalling pathway | 1.81E-15 | 1.69E-14 |
AGE-RAGE signalling pathway in diabetic complications | 2.46E-15 | 2.24E-14 |
AMPK signalling pathway | 8.08E-10 | 4.67E-09 |
Wnt signalling pathway | 3.92E-05 | 0.000121 |
RIG-I-like receptor signalling pathway | 5.64E-05 | 0.000171 |
Adrenergic signalling in cardiomyocytes | 6.58E-05 | 0.000197 |
